CodeSteri Launches PlaDeo: The World's First Bio-Plasma Powered Deodorant Device
A Breakthrough in Underarm Odor Control and Axillary Bromhidrosis Treatment
SEOUL, South Korea, June 17, 2025 /PRNewswire/ -- CodeSteri Inc., a tech-driven startup based at the Hanyang University College of Medicine in Seoul, today announced the launch of PlaDeo, the world's first electronic deodorant device powered by bio-plasma. Designed to eliminate underarm odor safely and effectively, PlaDeo offers a revolutionary approach to managing axillary bromhidrosis —a medical condition characterized by chronic underarm odor—without the use of chemicals, pore-blocking agents, or aluminum salts.
In 2020, PlaDeo—then branded Pragrant —was awarded the CES Innovation Award in the Health & Wellness category, recognizing its disruptive potential in personal care technology. Unlike conventional deodorants that mask odor using synthetic fragrances or suppress sweat glands, PlaDeo employs reactive oxygen species (ROS) —including hydroxyl radicals (OH⁻) and superoxide ions (O₂⁻)—to directly neutralize odor-causing bacteria and molecular residues on the skin. This plasma-powered mechanism ensures a non-toxic, non-residue, and skin-safe experience for daily users.
Scientifically Validated Performance
PlaDeo's efficacy has been scientifically proven. A peer-reviewed study published in Scientific Reports (2024), along with a clinical trial conducted at Hanyang University Hospital, demonstrated that 94% of participants experienced significant odor reduction after using the device regularly. These results validate PlaDeo as not only a hygiene product, but also a clinically relevant solution for those suffering from persistent body odor.
The launch of PlaDeo comes at a time when global consumers are actively seeking chemical-free, science-supported alternatives for personal hygiene. With increasing awareness of the long-term risks posed by ingredients such as triclosan and aluminum compounds, PlaDeo addresses a growing demand for effective, health-conscious innovation in the deodorant market. Its compact, travel-friendly form factor also makes it ideal for use in gyms, offices, eldercare environments, and hospitals—anywhere discretion and hygiene intersect.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
4 hours ago
- Korea Herald
Introducing the TELUS Mental Health Index: Nearly half of employees in South Korea experiencing feelings of depression and anxiety, impacting workplace productivity
More than one in three workers in South Korea have no emergency savings; women's mental health lags and more than two in five feel isolated SEOUL, South Korea, June 17, 2025 /PRNewswire/ -- Today, TELUS Health, a globally-recognized leader in workplace wellbeing, introduced its TELUS Mental Health Index ("the Index") to South Korea. Released quarterly, the Index measures and tracks employee mental health, wellbeing and productivity trends, providing organizations and policymakers with actionable insights to help build more resilient workforces. This quarter's report reveals that nearly half of employees in South Korea are experiencing feelings of depression and anxiety. The findings also show concerning trends: more than one in three workers have no emergency savings, women's mental health scores trail behind the average, and more than two in five employees report feelings of isolation. In 2024, TELUS Health expanded its Asia-Pacific presence through EZNwellness, South Korea's leading employee assistance program provider. EZNwellness enables deep insights into the working landscape in South Korea and strengthens TELUS Health's ability to deliver comprehensive wellbeing services and mental health support that resonates for employees and drives positive impacts for organizations. "The Index allows for comparisons with other developed nations, providing a clearer perspective on the mental health landscape among South Korean employees. The mental health challenges faced by South Korean workers have been widely reported and by tracking these trends over time, we gain valuable insights into how it is evolving," said Minjae Kang, CEO of EZNwellness, a TELUS Health Company. "The insights provide crucial guidance for businesses and policymakers striving to create healthier workplaces, and we're already seeing the value of coming together with TELUS Health, boosting our capacity to deliver tailored wellbeing research and solutions." The report reveals a concerning picture of mental health challenges affecting both workplaces and families in South Korea. Nearly one in three parents of school-age and teenage children worry about their child's mental health, contributing to lower mental health scores for parents, six points below the national average. The impact extends beyond home life, with 44 per cent of workers reporting feelings of isolation. These factors create a cycle of stress that strains family dynamics and workplace wellbeing, highlighting the interconnected nature of mental health issues across different aspects of life. T he TELUS Mental Health Index also found: "The research insights into the mental health and wellbeing of the workforce are essential for employers in creating supportive environments and cultivating resilience among their teams with a unified, regionally specific solution," said Paula Allen, Global Leader, Research & Client Insights, TELUS Health. "Prioritizing employee mental health and wellbeing can enhance organizational engagement, improve productivity, strengthen company culture, and drive sustainable business success." In the second quarter of 2025, the mental health scores of workers in various regions were: The lowest mental health score was reported in the Central region (53.1), followed by Honam (55.6). Workers in Yeognam and Seoul have slightly higher scores at 56.2 and 56.4, respectively. The Index is based on a response scoring system that turns individual responses into point values. Higher point values are associated with better mental health and less mental health risk. Scores between 0 to 49 correspond with distress levels, scores between 50 to 79 correspond with strain levels and scores between 80 to 100 correspond with optimal levels of mental health. This Index includes additional findings related to key psycho-social risks in the workplace, and mental health scores related to industry and other demographics. Read the full South Korean TELUS Mental Health Index here. As the parent company of TELUS Health, TELUS is committed to supporting the wellbeing of its own team members and their families through a flexible, comprehensive strategy. This approach is powered by the same innovative TELUS Health solutions trusted by Fortune 500 companies and has demonstrated real-world impact, with TELUS achieving a more than 20 per cent reduction in mental health disability claims among its own team members. Note to Editors About the TELUS Mental Health Index The research report is conducted globally to examine the mental health of employed people in New Zealand, Singapore, South Korea, Australia, the United Kingdom, the United States, Canada and Europe. The data for the TELUS Health Mental Health Index was collected through an online survey between March 14 and March 27, 2025, with 1,000 respondents. All respondents reside in South Korea and were employed within the last six months. The data has been statistically weighted to ensure the regional and gender composition of the sample reflects this population. About EZNwellness EZNwellness, a TELUS Health Company, is the leading employee assistance program (EAP) provider in South Korea. Founded in 2015 and based in Seoul, South Korea, EZNwellness provides EAP, digital mental health and psychological experience-based exhibition space. EZNwellness enhances traditional face-to-face EAP services by integrating diverse content, professional consulting at the organizational level, and digital innovations for seamless connection. This approach enables EZNwellness to deliver more comprehensive and effective EAP solutions tailored to modern workplace needs. For more information please visit: About TELUS Health TELUS Health is on a mission to become the most trusted wellbeing company in the world by enhancing the overall efficiency of healthcare and championing workplace wellbeing. By integrating advanced healthcare technology with comprehensive employee support services, TELUS Health provides a holistic approach to primary and preventive health and wellbeing enhancing more than 150 million lives across more than 200 countries and territories. Our innovative digital health platforms, including electronic medical records (EMRs) and virtual care solutions, empower healthcare professionals, employers and governments to deliver personalized care efficiently. Our employee wellbeing programs empower individuals by offering extensive support through Employee and Family Assistance Programs (EFAPs), mental health resources, financial counselling and workplace wellness initiatives. At TELUS Health, we are committed to revolutionizing healthcare to ensure people receive the support they need and employees thrive both personally and professionally. Together, let's make the future friendly. For more information please visit: Logo -
Korea Herald
14 hours ago
- Korea Herald
CodeSteri Launches PlaDeo: The World's First Bio-Plasma Powered Deodorant Device
A Breakthrough in Underarm Odor Control and Axillary Bromhidrosis Treatment SEOUL, South Korea, June 17, 2025 /PRNewswire/ -- CodeSteri Inc., a tech-driven startup based at the Hanyang University College of Medicine in Seoul, today announced the launch of PlaDeo, the world's first electronic deodorant device powered by bio-plasma. Designed to eliminate underarm odor safely and effectively, PlaDeo offers a revolutionary approach to managing axillary bromhidrosis —a medical condition characterized by chronic underarm odor—without the use of chemicals, pore-blocking agents, or aluminum salts. In 2020, PlaDeo—then branded Pragrant —was awarded the CES Innovation Award in the Health & Wellness category, recognizing its disruptive potential in personal care technology. Unlike conventional deodorants that mask odor using synthetic fragrances or suppress sweat glands, PlaDeo employs reactive oxygen species (ROS) —including hydroxyl radicals (OH⁻) and superoxide ions (O₂⁻)—to directly neutralize odor-causing bacteria and molecular residues on the skin. This plasma-powered mechanism ensures a non-toxic, non-residue, and skin-safe experience for daily users. Scientifically Validated Performance PlaDeo's efficacy has been scientifically proven. A peer-reviewed study published in Scientific Reports (2024), along with a clinical trial conducted at Hanyang University Hospital, demonstrated that 94% of participants experienced significant odor reduction after using the device regularly. These results validate PlaDeo as not only a hygiene product, but also a clinically relevant solution for those suffering from persistent body odor. The launch of PlaDeo comes at a time when global consumers are actively seeking chemical-free, science-supported alternatives for personal hygiene. With increasing awareness of the long-term risks posed by ingredients such as triclosan and aluminum compounds, PlaDeo addresses a growing demand for effective, health-conscious innovation in the deodorant market. Its compact, travel-friendly form factor also makes it ideal for use in gyms, offices, eldercare environments, and hospitals—anywhere discretion and hygiene intersect.
Korea Herald
17 hours ago
- Korea Herald
Global Action to End Smoking Welcomes Nataliia Toropova as Chief Development Officer
Toropova brings decades of experience in international public health and tobacco harm reduction to Global Action's team of experts committed to funding work to end the smoking epidemic. NEW YORK, June 16, 2025 /PRNewswire/ -- Global Action to End Smoking is pleased to announce the appointment of Nataliia "Natasha" Toropova as its new Chief Development Officer, effective immediately. "I'm honored to join Global Action, an organization that shares my own values of compassion for those who smoke and my vision of a world without smoking-related deaths," said Toropova. Natasha will lead Global Action's efforts to expand its philanthropic reach by funding critical research and initiatives that accelerate progress toward ending smoking worldwide. She brings decades of experience in public health, tobacco control, and fundraising including as a Programme Manager for the World Health Organization (WHO) and as an Advocacy Coordinator at Campaign for Tobacco Free Kids in Eastern Europe. In these roles, she not only promoted public health initiatives but also led successful fundraising campaigns to support their missions. Most recently, Natasha completed her six-year tenure as CEO of Healthy Initiatives, a nonprofit organization committed to strengthening public health by addressing the risk of non-communicable diseases in countries including Ukraine, Eastern Europe, and Central Asia. As a grantee of Global Action, Healthy Initiatives has educated hundreds of health care providers across nine countries in Eastern Europe and Central Asia on the benefits of tobacco harm reduction for people who cannot or will not quit smoking—especially amid the stress of global conflict. The team has also provided critical aid—including CAT tourniquets, ambulances, and mental health support—to the areas most impacted by the ongoing war in Ukraine. "Natasha brings a bold vision, deep expertise, and an unwavering commitment to public health," said Pam Parizek, Executive Board Chair of Global Action. "She's seen firsthand the positive impact Global Action's support can have to accelerate smoking cessation, and is the perfect person to lead our efforts to secure additional funding for this life-saving work." Natasha joins Global Action at a pivotal time as the organization reinvigorates its commitment to grantees. Through a recent reorganization, Global Action has ensured its ability to exist until its mission to end smoking is completed, allowing it to honor existing commitments and fund future grants. Natasha's development work will directly support Global Action's grantees, which currently include projects with organizations such as Northwell Health, the National Harm Reduction Coalition and ECLAT, a research-based spinoff of the University of Catania. She will work closely with the executive leadership team to carry out her fundraising and outreach duties. "Global Action remains steadfast in its commitment to its mission," said Heidi Goldstein, President and Chief Legal Officer of Global Action. "We have now guaranteed that our organization will last to see the end of the global smoking epidemic." About Global Action to End Smoking Global Action to End Smoking is an independent U.S. nonprofit 501(c)(3) grantmaking organization whose charitable mission is to end combustible tobacco use, which remains the leading preventable cause of death globally. Historically, Global Action received funding from PMI Global Services, Inc. (PMI). As of September 2023, Global Action and PMI terminated their original funding agreement, and Global Action formally adopted a policy not to seek or accept funding from companies that produce tobacco or non-medicinal nicotine products.
